Validity of composite end points in clinical trials

AUTOR(ES)

Montori, Victor M

FONTE

BMJ Publishing Group Ltd.

RESUMO

Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?

Documentos Relacionados

• Interpreting composite end points is challenging
• Points: Clinical trials and the acceptance of uncertainty
• Systematic adjudication of myocardial infarction end-points in an international clinical trial
• Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
• Validity and reliability of patient reported outcomes used in Psoriasis: results from two randomized clinical trials